ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Heart Disease is Down, Gout is Up, Biosimilars Confuse Patients and more from EULAR 2017

Heart Disease is Down, Gout is Up, Biosimilars Confuse Patients and more from EULAR 2017

  • EULAR 2017 (Photo courtesy of EULAR_6282)
    EULAR 2017 (Photo courtesy of EULAR_6282)
  • L. M. Thomsen, Danish Rheumatism Association. “Patient safety in relation to biosimilars – how can we act as a patient organization?” EULAR 2017. Madrid. Abstract: OP0328-PARE
  • E. Filhol, C. Gaujoux- Viala, B. Combe, J. Morel, et al. "Decrease in cardiovascular event excess risk in rheumatoid arthritis since 2000': A meta- analysis of controlled studies," EULAR 2017. Abstract: OP0146
  • M. I. Dehlin, V. Sigurdardottir, P. Drivelegka, A. Svärd, L. T. Jacobsson. "Trends and costs for gout hospitalization in Sweden," EULAR 2017. Abstract: OP0262; M. Doherty, W. Jenkins, H. Richardson, et al. "Nurse-Led Care Versus General Practitioner Care Of People With Gout: A Uk Community-Based Randomised Controlled Trial,” EULAR 2017. Abstract: OP0268
  • P. J. Mease, S. Hall, O. FitzGerald, et al. “Efficacy and Safety Of Tofacitinib, An Oral Janus Kinase Inhibitor, Or Adalimumab In Patients With Active Psoriatic Arthritis And An Inadequate Response To Conventional Synthetic Disease-Modifying Antirheumatic Drugs (Csdmards): A Randomised, Placebo-Controlled, Phase 3 Trial,” EULAR 2017. OP0216
  • M. Hagen, M. Englbrecht, J. Haschka, et al. “Multi-Biomarker Disease Activity and Autoantibody Status Lead to Cost Effective Tapering in Rheumatoid Arthritis Patients in Sustained Remission,” EULAR 2017. Abstract: OP0249
  • H.-H. Chen, W.-C. Chao, T.-L. Liao, et al. “Association Between a History Of Mycobacterial Infection and the Risk of Sjögren’s Syndrome: A Nationwide, Population-Based Case-Control Study,” EULAR 2017. Abstract: OP0074
  • X. Mariette, A. Flynn, F. Förger, et al. “Lack of Placental Transfer of Certolizumab Pegol During Pregnancy: Results From Crib, a Prospective, Postmarketing, Multicenter, Pharmacokinetic Study,” EULAR 2017. Abstract: OP0017
  • P. Raaschou, J. Söderling, J. Askling, et al. TNF Inhibitor Treatment and Risk of Cancer Recurrence in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study from Sweden,” EUALR 2017. Abstract: OP0308
  • A. Klein, G.-W. Just, S. G. Werner, I. Becker, et al. Fluorescence Optical Imaging in Juvenile Idiopathic Polyarticular Disease Before and During Antirheumatic Treatment,” EULAR 2017. Abstract: OP0057
  • M. Cutolo, V. Smith, O. Distler, O. Kowal-Bielecka, et al. “Preliminary Analysis of Nailfold Capillaroscopy in The Very Early Diagnosis of Systemic Sclerosis (Vedoss): The Capi-Vedoss Experience,” EULAR 2017. Abstract: OP0035

Cardiovascular disease is down in rheumatoid arthritis, but controlling gout flares remains a challenge for healthcare providers who presented their latest findings on this and other subjects at the European Congress of Rheumatology (EULAR) annual meeting in Madrid this week. The conference wraps up on Saturday, June 17. In this slideshow, we highlight some of the most popular presentations from the meeting.

Add new comment

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.